array(3) { ["company_details"]=> array(13) { ["name"]=> string(28) "Bristol-Myers Squibb Company" ["slug"]=> string(37) "81631-us-bristol-myers-squibb-company" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13" ["description"]=> string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html" ["address_street"]=> string(19) "430 E 29TH St FL 14" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1887-02-28" ["website_domain"]=> string(7) "bms.com" ["website_url"]=> string(19) "https://www.bms.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(1200) ["article_count"]=> int(2496) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(107) "Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RayzeBio, Inc. - RYZB" ["snippet_en"]=> string(270) "31.12.2023 - Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of RayzeBio, Inc. (NasdaqGM: RYZB) to Bristol-Myers Squibb Company (NYSE: BMY). Under the terms of ..." ["url"]=> string(217) "https://www.wallstreet-online.de/nachricht/17667816-rayzebio-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-proposed-sale-of-rayzebio-inc-ryzb" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e472c118-19dd-4bb8-af00-394b567cf29e" ["source"]=> string(20) "wallstreet-online.de" ["publication_date"]=> string(10) "2023-12-31" ["categories"]=> array(2) { [0]=> string(5) "Legal" [1]=> string(46) "Management of Legal and Regulatory Environment" } } [1]=> array(7) { ["title_en"]=> string(19) "Trouble in Paradise" ["snippet_en"]=> string(150) "The recent decision of the Hawai’i Supreme Court in State ex rel. Shikada v. Bristol-Myers Squibb Co., ___ P.3d ___, 2023 WL 2519857 (Haw. March 15," ["url"]=> string(69) "https://www.druganddevicelawblog.com/2023/04/trouble-in-paradise.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/71ac5b4b-0264-4bc9-b07c-1470486bbaab" ["source"]=> string(24) "druganddevicelawblog.com" ["publication_date"]=> string(10) "2023-03-31" ["categories"]=> array(4) { [0]=> string(5) "Legal" [1]=> string(46) "Management of Legal and Regulatory Environment" [2]=> string(15) "Business Ethics" [3]=> string(8) "Verdicts" } } [2]=> array(7) { ["title_en"]=> string(74) "The Inflation Reduction Act is Deflating America's Small Biotech Companies" ["snippet_en"]=> string(298) "President Biden is busy touting his party's signature legislation: the Inflation Reduction Act. He and fellow Democrats are particularly pleased with the IRA's drug-pricing provisions, which will impose price caps on a range of medicines covered by Medicare. But just as Democrats laud the supposed" ["url"]=> string(139) "https://townhall.com/columnists/karenkerrigan/2023/03/23/the-inflation-reduction-act-is-deflating-americas-small-biotech-companies-n2620994" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8fc0fbf1-0eae-433d-989a-09770d504d81" ["source"]=> string(12) "townhall.com" ["publication_date"]=> string(10) "2023-03-22" ["categories"]=> array(4) { [0]=> string(11) "US Politics" [1]=> string(17) "Academic Research" [2]=> string(46) "Management of Legal and Regulatory Environment" [3]=> string(11) "Legislation" } } [3]=> array(7) { ["title_en"]=> string(68) "U.S. Supreme Court Won't Decide Scope Of Wage-and-hour Class Actions" ["snippet_en"]=> string(222) "The U.S. Supreme Court on Monday again declined to settle a split among appeals courts over whether federal wage law allows workers to bring nationwide class action-style lawsuits, turning away a case involving FedEx Corp." ["url"]=> string(90) "https://www.ibtimes.com/us-supreme-court-wont-decide-scope-wage-hour-class-actions-3674204" ["image_url"]=> string(78) "https://images.businessradar.com/articles/301426fe-8ba2-4b1a-a17a-76090af8b973" ["source"]=> string(11) "ibtimes.com" ["publication_date"]=> string(10) "2023-03-06" ["categories"]=> array(7) { [0]=> string(8) "Verdicts" [1]=> string(15) "Labor Practices" [2]=> string(26) "Product Quality and safety" [3]=> string(46) "Management of Legal and Regulatory Environment" [4]=> string(5) "Legal" [5]=> string(15) "Business Ethics" [6]=> string(10) "Litigation" } } [4]=> array(7) { ["title_en"]=> string(64) "Bristol-Myers Rejected Again by High Court on $1.2B Gilead Award" ["snippet_en"]=> string(195) "Supreme Court again rejects Bristol-Myers Squibb bid to revive $1.2b patent-infringement award against Gilead Sciences in case over treatments that use body’s own immune system to fight cancer." ["url"]=> string(117) "https://news.bloomberglaw.com/health-law-and-business/bristol-myers-rejected-again-by-high-court-on-1-2b-gilead-award" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e1d6d576-4df4-4aa4-b9c9-8711e50cf766" ["source"]=> string(16) "bloomberglaw.com" ["publication_date"]=> string(10) "2023-01-09" ["categories"]=> array(4) { [0]=> string(5) "Award" [1]=> string(5) "Legal" [2]=> string(46) "Management of Legal and Regulatory Environment" [3]=> string(8) "Verdicts" } } [5]=> array(7) { ["title_en"]=> string(80) "BMS hits at Centre, state govt for failing to reconstitute welfare labour bodies" ["snippet_en"]=> string(143) "BMS also underlined that the Sustainable Development Goals (SDG) set by the United Nations (UN) have not been deliberated with the trade unions" ["url"]=> string(142) "https://www.hindustantimes.com/india-news/bms-hits-at-centre-state-govt-for-failing-to-reconstitute-welfare-labour-bodies-101667564012070.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/9a0c9ba5-0f11-4e0d-a016-104074fcae12" ["source"]=> string(18) "hindustantimes.com" ["publication_date"]=> string(10) "2022-11-04" ["categories"]=> array(2) { [0]=> string(19) "Green & Responsible" [1]=> string(46) "Management of Legal and Regulatory Environment" } } [6]=> array(7) { ["title_en"]=> string(72) "The Date For Assessing Disclosure Sufficiency – Is This An Open Issue?" ["snippet_en"]=> string(155) "Recently, the Federal Court of Appeal released its decision in Pharmascience Inc. v. Bristol-Myers Squibb Canada Co., 2022 2022 FCA 142 142 (the Decision)." ["url"]=> string(112) "https://www.mondaq.com/canada/patent/1228068/the-date-for-assessing-disclosure-sufficiency-is-this-an-open-issue" ["image_url"]=> string(78) "https://images.businessradar.com/articles/6cdecccc-f868-402b-aac7-97f6860a32bd" ["source"]=> string(10) "mondaq.com" ["publication_date"]=> string(10) "2022-09-07" ["categories"]=> array(3) { [0]=> string(5) "Legal" [1]=> string(46) "Management of Legal and Regulatory Environment" [2]=> string(8) "Verdicts" } } [7]=> array(7) { ["title_en"]=> string(82) "Jackson Lewis Class Action Trends Report 2022: Procedural issues take center stage" ["snippet_en"]=> string(187) "groundbreaking decision by the U.S. Court of Appeals for the Fifth Circuit changed the way district courts must handle plaintiffs’ motions for conditional certification in that circuit." ["url"]=> string(118) "https://www.natlawreview.com/article/jackson-lewis-class-action-trends-report-2022-procedural-issues-take-center-stage" ["image_url"]=> string(78) "https://images.businessradar.com/articles/7cfc9e97-47cd-4383-af51-100de8ceb57f" ["source"]=> string(16) "natlawreview.com" ["publication_date"]=> string(10) "2022-02-18" ["categories"]=> array(5) { [0]=> string(8) "Verdicts" [1]=> string(46) "Management of Legal and Regulatory Environment" [2]=> string(5) "Legal" [3]=> string(15) "Business Ethics" [4]=> string(10) "Litigation" } } [8]=> array(7) { ["title_en"]=> string(97) "Lifshitz Law Firm, P.C. Announces Investigations of Bristol-Myers Squibb Company (NYSE: BMY), ..." ["snippet_en"]=> string(43) "NEW YORK, Dec. 23, 2021 (GLOBE NEWSWIRE) --" ["url"]=> string(162) "https://www.djournal.com/lifshitz-law-firm-p-c-announces-investigations-of-bristol-myers-squibb-company-nyse-bmy/article_ad5dbdf7-e171-5686-9467-3e34e74a7e91.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a37556f5-0fe9-4715-bbfd-b782f688ca05" ["source"]=> string(12) "djournal.com" ["publication_date"]=> string(10) "2021-12-23" ["categories"]=> array(1) { [0]=> string(46) "Management of Legal and Regulatory Environment" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(254) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(163) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(151) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(94) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(89) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(76) } [6]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(74) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(64) } [8]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(63) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(60) } [10]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(60) } [11]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(56) } [12]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(54) } [13]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(47) } [14]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(47) } [15]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(45) } [16]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(45) } [17]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(42) } [18]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(39) } [19]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(35) } [20]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(35) } [21]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(33) } [22]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(32) } [23]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(27) } [25]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(22) } [28]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(21) } [29]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(21) } } } 81631-us-bristol-myers-squibb-company